Anna Broder

1.1k total citations
35 papers, 734 citations indexed

About

Anna Broder is a scholar working on Rheumatology, Nephrology and Immunology. According to data from OpenAlex, Anna Broder has authored 35 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 12 papers in Nephrology and 8 papers in Immunology. Recurrent topics in Anna Broder's work include Systemic Lupus Erythematosus Research (26 papers), Renal Diseases and Glomerulopathies (12 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Anna Broder is often cited by papers focused on Systemic Lupus Erythematosus Research (26 papers), Renal Diseases and Glomerulopathies (12 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Anna Broder collaborates with scholars based in United States, China and Israel. Anna Broder's co-authors include Chaim Putterman, Wenzhu Mowrey, Joel M. Kremer, George Reed, Nicole Jordan, Jonathan N. Tobin, Yumin Xia, Leal Herlitz, Béatrice Goilav and Jimmy J. Chan and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Clinical Pathology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Anna Broder

34 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Broder United States 15 486 341 144 113 101 35 734
E. K. Li China 18 702 1.4× 427 1.3× 83 0.6× 142 1.3× 129 1.3× 23 934
I-M Gilboe Norway 15 577 1.2× 312 0.9× 79 0.5× 71 0.6× 138 1.4× 17 882
Lena Schiffer Germany 19 536 1.1× 692 2.0× 247 1.7× 63 0.6× 191 1.9× 38 1.3k
Luís Inês Portugal 16 541 1.1× 458 1.3× 39 0.3× 72 0.6× 66 0.7× 62 837
Arthur F. Kavanaugh United States 13 371 0.8× 377 1.1× 64 0.4× 156 1.4× 59 0.6× 20 689
G. Castellino Italy 17 623 1.3× 343 1.0× 51 0.4× 81 0.7× 80 0.8× 32 934
Sandrine Jousse France 12 387 0.8× 313 0.9× 67 0.5× 44 0.4× 78 0.8× 22 764
Daniel J. Wallace United States 6 725 1.5× 461 1.4× 68 0.5× 112 1.0× 73 0.7× 9 896
C Dostál Czechia 14 347 0.7× 209 0.6× 103 0.7× 59 0.5× 56 0.6× 37 547
Javier Merayo‐Chalico Mexico 16 308 0.6× 314 0.9× 55 0.4× 52 0.5× 146 1.4× 41 667

Countries citing papers authored by Anna Broder

Since Specialization
Citations

This map shows the geographic impact of Anna Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Broder more than expected).

Fields of papers citing papers by Anna Broder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Broder. The network helps show where Anna Broder may publish in the future.

Co-authorship network of co-authors of Anna Broder

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Broder. A scholar is included among the top collaborators of Anna Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Broder. Anna Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Broder, Anna, Jennifer T. Aguilan, Simone Sidoli, et al.. (2023). Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients. Seminars in Arthritis and Rheumatism. 63. 152263–152263. 8 indexed citations
3.
Wu, Ming, Luis Chiriboga, Béatrice Goilav, et al.. (2022). Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study. Lupus Science & Medicine. 9(1). e000576–e000576. 15 indexed citations
4.
Ginsberg, Mindy, et al.. (2022). Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria. Clinical Journal of the American Society of Nephrology. 17(8). 1150–1158. 10 indexed citations
5.
Mowrey, Wenzhu, et al.. (2022). Association of Hydroxychloroquine Dose With Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research. 75(8). 1673–1680. 1 indexed citations
6.
Ramesh, Manish, Denisa Ferastraoaru, Golda Hudes, et al.. (2021). Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatology. 3(3). 133–137. 1 indexed citations
7.
Wahezi, Dawn M., et al.. (2020). Association of Medication Access Difficulty and COVID‐19–Related Distress With Disease Flares in Rheumatology Patients During the COVID‐19 Pandemic. Arthritis Care & Research. 73(8). 1162–1170. 19 indexed citations
8.
Bortnick, Anna E., Sanyog G. Shitole, Michael Park, et al.. (2020). Outcomes of ST‐elevation myocardial infarction by age and sex in a low‐income urban community: The Montefiore STEMI Registry. Clinical Cardiology. 43(10). 1100–1109. 10 indexed citations
9.
Mowrey, Wenzhu, et al.. (2020). Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease. BMC Nephrology. 21(1). 450–450. 4 indexed citations
10.
11.
Broder, Anna, Wenzhu Mowrey, Ladan Golestaneh, et al.. (2018). Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS. Seminars in Arthritis and Rheumatism. 48(4). 678–685. 3 indexed citations
12.
Broder, Anna, et al.. (2017). Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study. Seminars in Arthritis and Rheumatism. 47(4). 545–551. 47 indexed citations
13.
Park, Steven, et al.. (2017). The complex associations between obstructive sleep apnea and auto-immune disorders: A review. Medical Hypotheses. 110. 138–143. 21 indexed citations
14.
Mowrey, Wenzhu, et al.. (2016). Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis. Seminars in Arthritis and Rheumatism. 46(3). 286–290. 14 indexed citations
15.
Krathen, Michael, George Reed, Hong Chang, et al.. (2014). A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort. Arthritis & Rheumatology. 66(6). 1472–1481. 50 indexed citations
16.
Broder, Anna, Jonathan N. Tobin, & Chaim Putterman. (2012). High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study. Journal of Clinical Pathology. 65(6). 551–556. 8 indexed citations
17.
Xia, Yumin, Rahul D. Pawar, Antonio Nakouzi, et al.. (2012). The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. Journal of Autoimmunity. 39(4). 398–411. 44 indexed citations
18.
19.
Broder, Anna, Jimmy J. Chan, & Chaim Putterman. (2012). Dendritic cells: An important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases. Clinical Immunology. 146(3). 197–206. 30 indexed citations
20.
Broder, Anna, Jonathan N. Tobin, & Chaim Putterman. (2010). Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Research & Therapy. 12(5). R191–R191. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. K. Li Breakdown of academic impact, for papers by I-M Gilboe Breakdown of academic impact, for papers by Lena Schiffer Breakdown of academic impact, for papers by Luís Inês Breakdown of academic impact, for papers by Arthur F. Kavanaugh Breakdown of academic impact, for papers by G. Castellino Breakdown of academic impact, for papers by Sandrine Jousse Breakdown of academic impact, for papers by Daniel J. Wallace Breakdown of academic impact, for papers by C Dostál Breakdown of academic impact, for papers by Javier Merayo‐Chalico
Rankless by CCL
2026